Phase 4 Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 25 years old who are enrolled in the Nova Scotia Early Psychosis Program
Who may not be able to join:
- People who currently have a stimulant use disorder (such as a problematic pattern of using drugs like cocaine or amphetamines)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Philip G Tibbo, MD, Nova Scotia Health Authority
Phone: 902-473-7474
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in cannabis use; Treatment adherence; Change in white matter microstructure; Change in glial cell marker; Recruitment success
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.